Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,871 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study.
Numakura K, Kobayashi M, Ishida T, Okane K, Suzuki K, Shimoda N, Suzuki T, Kumazawa T, Sasaki R, Fukuda H, Kashima S, Yamamoto R, Koizumi A, Nara T, Kanda S, Huang M, Saito M, Narita S, Inoue T, Tsuchiya N, Habuchi T. Numakura K, et al. Among authors: kobayashi m. Eur Urol Focus. 2022 Nov;8(6):1666-1672. doi: 10.1016/j.euf.2022.06.002. Epub 2022 Jun 15. Eur Urol Focus. 2022. PMID: 35717522 Clinical Trial.
Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes.
Numakura K, Kobayashi M, Hatakeyama S, Naito S, Horikawa Y, Tanaka T, Kamada S, Muto Y, Yamamoto R, Koizumi A, Nara T, Kanda S, Saito M, Narita S, Inoue T, Shimoda N, Tsuchiya N, Ohyama C, Habuchi T. Numakura K, et al. Among authors: kobayashi m. Int J Clin Oncol. 2020 Aug;25(8):1543-1550. doi: 10.1007/s10147-020-01693-y. Epub 2020 May 11. Int J Clin Oncol. 2020. PMID: 32394047
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.
Narita T, Hatakeyama S, Numakura K, Kobayashi M, Muto Y, Saito M, Narita S, Tanaka T, Noro D, Tokui N, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C. Narita T, et al. Among authors: kobayashi m. Int J Urol. 2021 Sep;28(9):899-905. doi: 10.1111/iju.14601. Epub 2021 May 24. Int J Urol. 2021. PMID: 34028105
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.
Kobayashi M, Narita S, Matsui Y, Kanda S, Hidaka Y, Abe H, Tsuzuki T, Ito K, Kojima T, Kato M, Hatakeyama S, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Kamiyama M, Morita S, Habuchi T, Ogawa O, Nishiyama H, Kitamura H, Kobayashi T; Japan Urological Oncology Group. Kobayashi M, et al. Among authors: kobayashi t. BJU Int. 2022 Aug;130(2):226-234. doi: 10.1111/bju.15510. Epub 2021 Jul 6. BJU Int. 2022. PMID: 34110696
Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer.
Kobayashi M, Fujiyama N, Tanegashima T, Narita S, Yamamoto Y, Fujimoto N, Ueda S, Takeuchi A, Numakura K, Habuchi T, Matsuyama H, Eto M, Shiota M. Kobayashi M, et al. Cancer Immunol Immunother. 2022 Mar;71(3):727-736. doi: 10.1007/s00262-021-03032-0. Epub 2021 Aug 11. Cancer Immunol Immunother. 2022. PMID: 34379177 Free PMC article.
11,871 results
You have reached the last available page of results. Please see the User Guide for more information.